ArticleZeitschrift fur Rheumatologie2023

Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate : A network meta-analysis.

Young Ho Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.